ALKERMES PLC. (ALKS)

Director snyderman nancy lynn MD 🟡 adjusted position in 44.5K shares (2 derivative) of Alkermes plc. (ALKS) at $50.35 ($6.4M) Transaction Date: Aug 03, 2026 | Filing ID: 000111

Register to leave comments

  • News bot Aug. 3, 2026, 11:17 p.m.

    🔍 snyderman nancy lynn MD (Director)

    Company: Alkermes plc. (ALKS)

    Report Date: 2026-08-03

    Transaction Summary:

    • Total transactions: 6
    • Derivative instruments: 2
    • Holdings reported: 1
    • Total shares acquired: 44,472
    • Total shares sold: 88,944
    • Total shares held: 20,783

    Detailed Transactions and Holdings:

    • Acquired 27,948 shares of Ordinary Shares at $46.72 per share (Direct)
      Date: 2026-08-03 | Code: M | equity_swap_involved: 0 | shares_owned_after: 43,343.00 | transaction_form_type: 4
    • Acquired 16,524 shares of Ordinary Shares at $46.72 per share (Direct)
      Date: 2026-08-03 | Code: M | equity_swap_involved: 0 | shares_owned_after: 59,867.00 | transaction_form_type: 4
    • Sold 44,472 shares of Ordinary Shares at $50.348 per share (Direct)
      Date: 2026-08-03 | Code: S | equity_swap_involved: 0 | shares_owned_after: 15,395.00 | transaction_form_type: 4 | Footnotes: F1
    • Holds 0 shares of Ordinary Shares (Direct)
      Date: 2026-08-03 | Code: H | nature_of_ownership: By the Snyderman Trust | shares_owned_after: 20,783.00 | Footnotes: F2
    • Sold 27,948 shares of Non Qualified Stock Option (Right to Buy) at $46.72 per share (Derivative)
      Date: 2026-08-03 | Code: M | Expires: 2026-09-14 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F3
    • Sold 16,524 shares of Non Qualified Stock Option (Right to Buy) at $46.72 per share (Derivative)
      Date: 2026-08-03 | Code: M | Expires: 2026-09-14 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F3

    Footnotes:

    • F1: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $50.07 to $50.70. Full information regarding the number of shares sold at each separate price can be provided to the issuer, any security holder of the issuer or the SEC staff upon request.
    • F2: Shares are held by the Nancy Lynn Snyderman Revocable Trust (the "Snyderman Trust"), of which the reporting person is both the sole trustee and sole beneficiary.
    • F3: These options are fully vested in accordance with their terms.